Cargando…
Association between protective efficacy of anti-lipopolysaccharide (LPS) antibodies and suppression of LPS-induced tumor necrosis factor alpha and interleukin 6. Comparison of O side chain-specific antibodies with core LPS antibodies
Two-core LPS antibodies, the rabbit J5 polyclonal antiserum and the human anti-lipid A IgM mAb HA-1A, did not improve the survival of mice challenged with E. coli O111 or P. aeruginosa 3, or with the LPS extracted from them, and did not decrease the incidence of Shwartzman reactions in rabbits chall...
Formato: | Texto |
---|---|
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
1990
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2187790/ https://www.ncbi.nlm.nih.gov/pubmed/2307935 |
Ejemplares similares
-
Lipopolysaccharide (LPS)-binding protein accelerates the binding of LPS to CD14
Publicado: (1994) -
Lipopolysaccharide (LPS)-binding protein is carried on lipoproteins and acts as a cofactor in the neutralization of LPS
Publicado: (1994) -
T Cell Stimulation In Vivo by Lipopolysaccharide (LPS)
por: Tough, David F., et al.
Publicado: (1997) -
Lipopolysaccharide (LPS) Inner-Core Phosphates Are Required for Complete LPS Synthesis and Transport to the Outer Membrane in Pseudomonas aeruginosa PAO1
por: DeLucia, Angela M., et al.
Publicado: (2011) -
Outer membrane protein size and LPS O-antigen define protective antibody targeting to the Salmonella surface
por: Domínguez-Medina, C. Coral, et al.
Publicado: (2020)